BioCentury
ARTICLE | Financial News

AccuraGen raises $40M in series B

June 2, 2016 12:56 AM UTC

Cancer diagnostics company AccuraGen Holdings Ltd. (Menlo Park, Calif.) raised $40 million in a series B round. Junson Capital, Decheng Capital, Temasek Investments, DT Capital, Stanford-StartX Fund and Nan Fung Capital participated, along with existing investors. The company's 2015 series A round included Denlux Capital, Yifang Group Holdings Ltd. and WS Investment, as well as Decheng.

AccuraGen's Firefly platform is designed to detect cancer mutations in circulating cell-free DNA (cfDNA). ...